Stephanie Davis
Stock Analyst at Barclays
(4.2)
Main Sectors:
32 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DGX Quest Diagnostics | Maintains: Equal-Weight | 185 190 | 179.52 | 5.84% | 6 | Oct 2, 2025 | |
WAY Waystar Holding | Maintains: Overweight | 50 45 | 38.64 | 16.46% | 6 | Apr 14, 2025 | |
OPRX OptimizeRx | Maintains: Equal-Weight | 11 5 | 18.75 | -73.33% | 3 | Nov 14, 2024 | |
DOCS Doximity | Maintains: Overweight | 52 75 | 73.25 | 2.39% | 5 | Nov 11, 2024 | |
LFST LifeStance Health Gr | Maintains: Underweight | 6 7 | 5.51 | 27.04% | 2 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 6 | 4.53 | 32.45% | 7 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 39 19 | 8.21 | 131.43% | 1 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 263 290 | 302.72 | -4.2% | 2 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 24 | 27.9 | -13.98% | 3 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 154.46 | -13.89% | 2 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 39 58 | 30.95 | 87.4% | 2 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 3 | 2.76 | 8.7% | 7 | Oct 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | 26.46 | -97.17% | 3 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | n/a | n/a | 10 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 213 249 | 276.83 | -10.05% | 3 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 14 14 | n/a | n/a | 6 | Feb 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 10 | n/a | n/a | 6 | Jan 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 23.29 | 24.52% | 11 | Jan 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 11 | n/a | n/a | 10 | Jan 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 34 | 9.02 | 276.94% | 9 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 59 34 | 20.59 | 65.13% | 3 | Jan 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 242 233 | 296.33 | -21.37% | 9 | Dec 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 17 | 2.96 | 474.32% | 10 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | n/a | n/a | 6 | Oct 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 76 | 88.59 | -14.21% | 5 | Jun 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 11 4 | n/a | n/a | 7 | May 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 88 95 | n/a | n/a | 4 | Dec 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 34 36 | n/a | n/a | 4 | Oct 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 45 41 | n/a | n/a | 4 | Aug 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 56 | n/a | n/a | 7 | May 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 53 | n/a | n/a | 2 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 35 | n/a | n/a | 2 | Aug 10, 2020 |